Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Sex hormones and modulators

FDA 1977

3-oxoandrosten (4) derivatives

Methyltestosterone

Approved 2 Feb 1977Buccal, Under the tongueTablet

The FDA lists this product in 34 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: METHYLTESTOSTERONE 10MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

METHYLTESTOSTERONE 10MG · TabletANDA080767-002 · Prescription
METHYLTESTOSTERONE 10MG · TabletThis page
METHYLTESTOSTERONE 10MG · TabletANDA080839-001 · Discontinued
METHYLTESTOSTERONE 10MG · TabletANDA080933-001 · Discontinued
METHYLTESTOSTERONE 10MG · TabletANDA084287-001 · Discontinued
METHYLTESTOSTERONE 25MG · TabletANDA084642-001 · Discontinued
METHYLTESTOSTERONE 25MG · TabletANDA084241-001 · Discontinued
METHYLTESTOSTERONE 10MG · TabletANDA087092-001 · Discontinued
METHYLTESTOSTERONE 10MG · CapsuleANDA215270-001 · Prescription
METHYLTESTOSTERONE 25MG · TabletANDA080214-003 · Discontinued
METHYLTESTOSTERONE 5MG · Tablet

More in sex hormones and modulators

Conjugated Estrogensestrogens, conjugated · Tablet
EnzalutamideTablet

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA080214-001 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA080214-002 · Discontinued

METHYLTESTOSTERONE 10MG · CapsuleANDA204851-001 · Prescription

METHYLTESTOSTERONE 10MG · TabletANDA080271-001 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA080308-001 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA080310-001 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA084310-001 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA085270-001 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA080475-003 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA080475-001 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA080475-002 · Discontinued

METHYLTESTOSTERONE 10MG · CapsuleANDA084967-001 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA080931-001 · Discontinued

METHYLTESTOSTERONE 5MG · TabletANDA083836-001 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA080309-001 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA084244-001 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA084312-001 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA084331-001 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA084331-002 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA080256-002 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA080256-001 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA080973-001 · Discontinued

METHYLTESTOSTERONE 10MG · TabletANDA080313-001 · Discontinued

METHYLTESTOSTERONE 25MG · TabletANDA087111-001 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA085125.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Methyltestosterone
Drug class: 3-oxoandrosten (4) derivatives, Androgens and female sex hormones in combination with other drugs
Group: Sex hormones and modulators
Route: Buccal, Under the tongue
Dosage form: Tablet
Applicant: Tablicaps
Status: Discontinued
FDA approval: 2 Feb 1977
Application: ANDA085125-001
RxCUI: 6904

Guidelines

Guidelines in obstetrics and gynaecology1,051 guidelines in the library

FDA 2024

Femlyvethinyl estradiol · Tablet, orally disintegrating

FDA 2024EstradiolGel, metered

FDA 2024OspemifeneTablet

FDA 2023Enilloringethinyl estradiol · Ring

FDA 2023Orserduelacestrant hydrochloride · Tablet

FDA 2023Emzahhnorethindrone · Tablet

FDA 2022Haloetteethinyl estradiol · Ring

FDA 2021Veraringethinyl estradiol · Ring

FDA 2021Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarateethinyl estradiol · Capsule

FDA 2021Ethinyl Estradiol and Norelgestrominethinyl estradiol · Film, extended release

FDA 2021Ethinyl Estradiol; Etonogestrelethinyl estradiol · Ring

FDA 2020Dolishaleethinyl estradiol · Tablet

FDA 2020Winleviclascoterone · Cream

FDA 2020Xtandienzalutamide · Tablet

FDA 2020Finzalaethinyl estradiol · Tablet

FDA 2020Twirlaethinyl estradiol · System